[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349899-105":59,"doc-detail-349899-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","epithelial-mesenchymal-plasticity-and-immunosuppression-in-canine-carcinomas-reveals-cross-species-upregulation-of-cd109","Epithelial-mesenchymal plasticity and immunosuppression in canine carcinomas reveals cross-species upregulation of CD109","","Epithelial–mesenchymal plasticity (EMP) is investigated as a driver of metastasis, chemoresistance, and immune evasion in spontaneous canine mammary carcinomas. Building on prior murine findings linking EMP to immunosuppressive tumor microenvironments and immune-checkpoint therapy resistance, the study shows EMP-associated recruitment of immunosuppressive cells in dogs. It identifies glycoprotein CD109 as associated with EMP-mediated immunosuppression across canine, murine, and human cancer models and reports shared upregulation of immunosuppressive factors among multiple canine carcinomas, supporting translational implications for human breast cancer.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/epithelial-mesenchymal-plasticity-and-immunosuppression-in-canine-carcinomas-reveals-cross-species-upregulation-of-cd109/349899/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/epithelial-mesenchymal-plasticity-and-immunosuppression-in-canine-carcinomas-reveals-cross-species-upregulation-of-cd109/349899.png","ImageObject",300,407,{"name":92,"@type":93},"Miles","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What links epithelial–mesenchymal plasticity (EMP) to cancer progression in this work?","Question",{"text":113,"@type":114},"EMP activation enables carcinoma cells to drive metastasis and chemoresistance and is associated with immunotherapy resistance through changes in the tumor microenvironment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How are canine mammary carcinomas used to test whether EMP is conserved?",{"text":118,"@type":114},"The study analyzes spontaneous canine mammary carcinomas and evaluates whether EMP is linked to recruitment of immunosuppressive cells, paralleling findings from murine models.",{"name":120,"@type":111,"acceptedAnswer":121},"What role does CD109 play in EMP-mediated immunosuppression?",{"text":122,"@type":114},"CD109 is identified as associated with EMP-mediated immunosuppression across canine, murine, and human models, extending prior work where it was linked to tumorigenicity but not immunosuppression.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},349899,1790551815,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},13056703019404,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","communications biology Article  \nA Nature Portfolio journal  \n[https://doi.org/10.1038/s42003-026-09587-x](https://doi.org/10.1038/s42003-026-09587-x)  \nEpithelial-mesenchymal plasticity and immunosuppression incanine carcinomas reveals cross-species upregulation of CD109  \n Check for updates  \n\n| Kimaya Bakhle 1, Sophie Nelissen2, Lynna Li1, Ioannis Ntekas3, Iwijn De Vlaminck3, Santiago Peralta 4, Andrew D. Miller2 & Anushka Dongre 1  |  |\n| --- | --- |\n| Epithelial-mesenchymal plasticity (EMP) is activated in carcinoma cells to drive metastasis and chemoresistance. Recently, we demonstrated that EMP activation results in an immunosuppressive tumor microenvironment and immunotherapy resistance in a syngeneic orthotopic murine model. However, it has yet to be shown whether this is conserved incanine carcinomas. Here, we show that in spontaneous canine mammary carcinomas (CMCs), which share clinical and molecular features with human breast cancers, EMP is linked to the recruitment of immunosuppressive cells. Additionally, we identify that the glycoprotein CD109 is associated with EMP-mediated immunosuppression incanine, murine, and human models. CD109 has been associated with tumorigenicity, but not immunosuppression in cancers of any species. Finally, we identiﬁed shared upregulation of immunosuppressive factors across multiple canine carcinomas, including oral squamous cell carcinoma, urothelial carcinoma, and pulmonary carcinoma. These ﬁndings demonstrate that EMP is associated with immunosuppression in canine carcinomas, with translational implications for human breast cancers. |  |\n| The epithelial–mesenchymal transition (EMT) is a cell-biological process that enables epithelial cells, which express the markers EpCAM and Ecadherin, to gain mesenchymal markers, such as vimentin and N-cadherin, and features including invasiveness, metastatic potential, and stem-cell-like properties1–8. In neoplasia, these malignant features lead to recurrent, invasive primary tumors as well as notoriously incurable metastatic disease6,9–11. These changes are driven by EMT-inducing transcription factors (EMT-TFs) Zeb1, Twist, Slug, and Snail. EMT-TFs are activated by several signaling molecules secreted by stromaland immune cells within the tumor microenvironment (TME)12–16. These molecules include TGF-β, WNT ligands, NOTCH receptor ligands, epidermal growth factor (EGF),ﬁbroblast growth factor (FGF), hepatocyte growth factor (HGF), plateletderived growth factor (PDGF), IL-6, CCL18, and tumor necrosis factor (TNF)8. Importantly, the EMT program is a dynamic process that results ina spectrum of hybrid or quasi-mesenchymal states, which express both epithelial and mesenchymal markers. Moreover, mesenchymal cells can | mesenchymal-to-epithelial transition. Accordingly, this program is increasingly being recognized as epithelial–mesenchymal plasticity (EMP)8, 17–20.\u003Cbr>We have previously identiﬁed that EMP within murine mammary cancers determines responses to immune attack21,22. We established novel, preclinical murine models of epithelial and quasi-mesenchymal mammary tumors, using cell lines derived from the autochthonous mouse mammary tumor virus-polyoma middle T antigen(MMTV-PyMT) model. Using this model, we determined that epithelial tumors assembled an immunopermissive TME, in which the tumors were densely inﬁltrated by CD8+ T-cells and anti-tumor M1-like macrophages were restricted to the tumor periphery8,21. Conversely, quasi-mesenchymal tumors excluded exhausted CD8+ T-cells to the periphery and instead recruited regulatory T-cells (Tregs) and pro-tumor M2-like macrophages21. Findings of EMPassociated immunosuppression have also been reported in murine models of other cancer types, including melanoma, lung adenocarcinoma, and |\n| revert to the epithelial state by activating the reverse process of hepatocellular carcinoma23–25. These alterations in the TME also resulted in |  |\n\n1Department of Biomedical Sciences, College of Veterinary Me","cbCaigmrPUcDbupw","https://ap.wps.com/l/cbCaigmrPUcDbupw","pdf",3327955,14,"English","# Overview\n## EMT and transition to EMP\n## EMP and immune responses in murine models\n## Canine mammary carcinomas and immunosuppressive recruitment\n## CD109 and cross-species immunosuppression\n## Shared upregulation across canine cancers","[{\"question\":\"What links epithelial–mesenchymal plasticity (EMP) to cancer progression in this work?\",\"answer\":\"EMP activation enables carcinoma cells to drive metastasis and chemoresistance and is associated with immunotherapy resistance through changes in the tumor microenvironment.\"},{\"question\":\"How are canine mammary carcinomas used to test whether EMP is conserved?\",\"answer\":\"The study analyzes spontaneous canine mammary carcinomas and evaluates whether EMP is linked to recruitment of immunosuppressive cells, paralleling findings from murine models.\"},{\"question\":\"What role does CD109 play in EMP-mediated immunosuppression?\",\"answer\":\"CD109 is identified as associated with EMP-mediated immunosuppression across canine, murine, and human models, extending prior work where it was linked to tumorigenicity but not immunosuppression.\"}]","Epithelial-mesenchymal plasticity and immunosuppression in canine carcinomas reveals cross-species upregulation of CD109 | PDF",1790086142,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b428fd614bfde9ddf17c61a7273267d7.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b7c60ab38da7cde8ddbb009ae446611.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aaaf9a32c80c9dc7c87ba2fbc88f0d09.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/baf8e362e6d7ecdc74bb2407928094d2.webp",980,1301]